DiamiR Biosciences: Fred Knechtel
Aug 30, 2022
DiamiR Biosciences has appointed of Fred Knechtel as its new chief financial officer. Knechtel is currently the co-founder, CFO, and director of NorthView Acquisition, a Special Purpose Acquisition Company focusing on mergers in the life sciences and healthcare industry. He has previously served as CFO for Interpace Biosciences, CFO of GENEWIZ, CFO of Sims Metal management, and CFO of Remy International.